Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Merg who wrote (1101)	9/15/1998 8:43:00 PM
From: mesaone	Read Replies (1) of 1432

Hespan causes coaguation problems when used in amounts above about one liter and albumin has been shown to cause increased mortality. The only other possible solution close to reaching the market to treat hypovolemia caused by trauma or surgery is BioTime's Hextend, which has been shown to be safe and effective in Phase III clinical trials. Hextend also demonstrated superior coagulation performance and required use of less blood products (including PPF) in these trials in comparison to Hespan. Please check out my web site for futher information about the BioTime story. inch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next